Diffusion-weighted Imaging as a Treatment Response Biomarker for Evaluating Bone Metastases in Prostate Cancer: A Pilot Study
Open Access
- 1 April 2017
- journal article
- research article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 283 (1) , 168-177
Abstract
Assessment of bone metastases with whole-body diffusion-weighted imaging during cancer treatment is feasible, with changes in bone metastases volume and median apparent diffusion coefficient being ... PurposeTo determine the usefulness of whole-body diffusion-weighted imaging (DWI) to assess the response of bone metastases to treatment in patients with metastatic castration-resistant prostate ca...Keywords
Funding Information
- Stand Up To Cancer (SU2C-AACR-DT0712)
- Cancer Research UK (C12540/A12829)
- Prostate Cancer UK (PG14-016-TR2)
- Prostate Cancer Foundation (20131017)
This publication has 26 references indexed in Scilit:
- Inter- and Intra-Observer Repeatability of Quantitative Whole-Body, Diffusion-Weighted Imaging (WBDWI) in Metastatic Bone DiseasePLOS ONE, 2016
- Clinical Application of Diffusion-Weighted Magnetic Resonance Imaging in Uterine Cervical CancerInternational Journal of Gynecological Cancer, 2015
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012International Journal of Cancer, 2014
- Metastatic Ovarian and Primary Peritoneal Cancer: Assessing Chemotherapy Response with Diffusion-weighted MR Imaging—Value of Histogram Analysis of Apparent Diffusion CoefficientsRadiology, 2011
- Assessing response in bone metastases in prostate cancer with diffusion weighted MRIEuropean Radiology, 2011
- Envisioning the future of early anticancer drug developmentNature Reviews Cancer, 2010
- Treatment of Hormone-Refractory Prostate Cancer with Docetaxel or Mitoxantrone: Relationships between Prostate-Specific Antigen, Pain, and Quality of Life Response and Survival in the TAX-327 StudyClinical Cancer Research, 2008
- Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working GroupJournal of Clinical Oncology, 2008
- A Feasibility Study Evaluating the Functional Diffusion Map as a Predictive Imaging Biomarker for Detection of Treatment Response in a Patient with Metastatic Prostate Cancer to the BoneNeoplasia, 2007
- Diffusion-weighted MR Imaging in Monitoring the Effect of a Vascular Targeting Agent on Rhabdomyosarcoma in RatsRadiology, 2005